Cargando…
LncRNA FENDRR Expression Correlates with Tumor Immunogenicity
FENDRR (Fetal-lethal non-coding developmental regulatory RNA, LncRNA FOXF1-AS1) is a recently identified tumor suppressor long non-coding (LncRNA) RNA, and its expression has been linked with epigenetic modulation of the target genes involved in tumor immunity. In this study, we aimed to understand...
Autores principales: | Munteanu, Maria Cristina, Sethuraman, Sri Nandhini, Singh, Mohit Pratap, Malayer, Jerry, Ranjan, Ashish |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226633/ https://www.ncbi.nlm.nih.gov/pubmed/34200642 http://dx.doi.org/10.3390/genes12060897 |
Ejemplares similares
-
Boiling histotripsy and in-situ CD40 stimulation improve the checkpoint blockade therapy of poorly immunogenic tumors
por: Singh, Mohit Pratap, et al.
Publicado: (2021) -
Novel calreticulin-nanoparticle in combination with focused ultrasound induces immunogenic cell death in melanoma to enhance antitumor immunity
por: Sethuraman, Sri Nandhini, et al.
Publicado: (2020) -
LncRNA FENDRR attenuates colon cancer progression by repression of SOX4 protein
por: Liu, Jianchao, et al.
Publicado: (2019) -
The effect of splicing MST1R in gastric cancer was enhanced by lncRNA FENDRR
por: Zhou, Donghui, et al.
Publicado: (2021) -
LncRNA FENDRR-mediated tumor suppression and tumor-immune microenvironment changes in non-small cell lung cancer
por: Pan, Hongyu, et al.
Publicado: (2020)